Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-01-23
1993-06-22
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548452, A61K 3140, C07D20952
Patent
active
052216896
ABSTRACT:
The present invention relates to novel isomers of 6,9.alpha.-nitrilo-PGI.sub.1 s having a specific steric configuration, which are replaced by an alkyl (C.sub.1 to C.sub.8)-substituted cycloalkyl (C.sub.4 to C.sub.7) group in (1S,S) form, in (1S,R) form or in cis form at the 15-, 16- or 17-position of the PG skeleton, and, alkyl esters thereof, non-toxic salts thereof, non-toxic acid addition salts thereof and cyclodextrin clathrates thereof, possessing more potent PG-like pharmacological activity than other isomers.
REFERENCES:
patent: 4180675 (1979-12-01), Hayashi
patent: 4220795 (1980-09-01), Kluendes
patent: 4234597 (1980-11-01), Hayashi
patent: 4275075 (1981-06-01), Kurono
patent: 4278088 (1981-07-01), Hyayashi
patent: 4479966 (1984-10-01), Hayashi
patent: 4562207 (1985-12-01), Imaki
Imaki, Adv. Prost. Res. 19, pp. 666-669 (1988).
Imaki Katsuhiro
Miyake Hajimi
Okegawa Tadao
Gerstl Robert
Ono Pharmaceutical Co. Ltd.
LandOfFree
Prostaglandin analogues, processes for their preparation and pha does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin analogues, processes for their preparation and pha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin analogues, processes for their preparation and pha will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441261